Christian Schulze Presents The Post-Hoc Analysis of the DanGer Shock Trial
Christian Schulze, Professor of Medicine at Friedrich-Schiller-University Jena, shared on LinkedIn:
”Escalation of Mechanical Circulatory Support in Patients with STEMI-related Cardiogenic Shock: A post-hoc Analysis of the DanGer Shock Trial.
Escalation to tMCS occurred in almost 1/5 patients, was more likely in the control group, and was associated with a higher mortality risk.
Even with early escalation (<1 hour), patients escalated from the control group had the highest mortality, underscoring the need for future trials to define optimal escalation strategies.”
Read the full article here.
Article: Escalation of Mechanical Circulatory Support in Patients with STEMI-related Cardiogenic Shock: A post-hoc Analysis of the DanGer Shock Trial
Authors: Benedikt Schrage; Rasmus Paulin Beske; Christian Hassager; Lisette Okkels Jensen; Hans Eiskjær; Norman Mangner; Amin Polzin; P Christian Schulze; Carsten Skurk; Peter Nordbeck; Vasileios Panoulas; Sebastian Zimmer; Andreas Schäfer; Nikos Werner; Thomas Engstrøm; Lene Holmvang; Nanna Louise Junker Udesen; Henrik Schmidt; Anders Junker; Christian Juhl Terkelsen; Steffen Christensen; Axel Linke; Dirk Westermann; Peter Clemmesen; Jacob Eifer Møller
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 31, 2026, 06:27Negative Trials Matter: Anne Hege Aamodt Shares The TenCRAOS Trial
-
Jan 31, 2026, 06:18Manuel Requena: Cherrypicking Inclusion in Clinical Trials May Underestimate The Effect of An Intervention
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained